ASPR's IBx Portfolio
Description of Project: OraSure Technologies Inc. was contracted to retrofit a production facility and a new additional facility with machinery to increase domestic manufacturing capability of rapid antigen self-tests for home care testing.
Unique Impact: These investments are an integral part of the Administration’s strategy to expand COVID-19 testing and make tests more widely available for Americans as we work to slow the spread of COVID-19 and protect public health.
Base Award Amount: $109,000,000.00
Category: Testing Capacity and Raw Materials